FlowBank

1111 days ago • Posted by Martin Boujol

Vir Biotechnology: why did the stock soar yesterday?

Shares of Vir Biotechnology (NASDAQ:VIR) soared 32% yesterday as the company announced a promising clinical trial for its Covid-19 anti-body treatment. According to the test, this solution could reduce hospitalization or death by 85%.

Source: NASDAQ

Vir Biotechnology: why did the stock soared yesterday?
bg_newsletter